Chromocell Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · IEX Real-Time Price · USD
1.110
-0.040 (-3.48%)
At close: Jul 19, 2024, 4:00 PM
1.120
+0.010 (0.90%)
Pre-market: Jul 22, 2024, 4:27 AM EDT
Chromocell Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for CHRO.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for CHRO is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 |
|---|---|
| Strong Buy | 1 |
| Buy | 0 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jun 18, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.